Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Yvonne Wassenaar, a member of Arista Networks Inc's board, sold 1,395 shares on April 15, 2026, for a total of $213,532 under a pre-established Rule 10b5-1 plan. The sales were executed at prices between $151.0697 and $154.72. After the trades, Wassenaar retains direct ownership of 9,784 shares. The move comes amid a wave of positive analyst commen…
Alistair N Sporck, vice president of the Contactor Business Unit at Aehr Test Systems (NASDAQ:AEHR), sold 2,000 shares on April 16, 2026, generating $163,760. The transaction comes while the stock trades close to a 52-week peak after a 937% year-over-year gain. The company also reported a record $41 million production order from a hyperscale custom…
Lynne Parshall, a director at Ionis Pharmaceuticals (IONS), sold 5,000 shares on April 15, 2026, in two transactions totaling $381,366 under a Rule 10b5-1 plan adopted May 6, 2025. The disposals come as the stock has risen 167% over the past year and ahead of an April 29 earnings report. Multiple analyst actions and a new pricing strategy for Tryng…
Ionis Pharmaceuticals Executive Vice President Kyle Jenne sold 4,902 shares on April 16, 2026 in an automatic tax-withholding transaction tied to recently vested restricted stock units. The sale totaled $368,488 at a weighted average price of $75.171. The move comes amid notable analyst activity and new pricing for Tryngolza, with several firms rei…
Joseph Baroldi, Ionis Pharmaceuticals' Executive Vice President and Chief Business Officer, disposed of 5,619 shares on April 16, 2026, in a transaction recorded on a Form 4. The trade, executed at a weighted average price of $74.56 per share and totaling $418,952, coincided with the vesting and release of 10,837 restricted stock units valued at $0…
Brian Birchler, executive vice president at Ionis Pharmaceuticals, sold 973 shares on April 16, 2026, to satisfy tax withholding tied to vested restricted stock units. The sales totaled about $73,015 at a weighted average price of $75.042. Ionis shares trade at $75.71, up 167% over the past year, while several analysts have updated their ratings an…
Photronics director Lee Kang Jyh sold 10,000 shares on April 15, 2026, for $45.1 each, netting $451,000 and leaving him with 375,850 shares. The trade occurred while PLAB shares traded at $48.38, close to a 52-week peak, after a 174% year-over-year gain. Separately, Photronics reported fiscal Q1 2026 results above expectations, saw a price-target l…
Zachary M. Briers, Snap Inc.'s general counsel, sold 11,437 Class A shares on April 15, 2026, for $6.04 each, netting $69,079. The trade was made under a Rule 10b5-1 plan adopted November 17, 2025. The disclosure coincides with Snap's pre-announced first-quarter 2026 results and a workforce reduction intended to generate significant cost savings.
Snap Inc. Chief Business Officer Mohan Ajit sold 28,058 shares of Class A common stock on April 16, 2026, at a weighted average price of $6.0179, generating $168,850 in proceeds. The filing states the sale was made to meet tax withholding obligations tied to the settlement and release of restricted stock units. The transaction was carried out by Ma…
Elizabeth Bhatt, President and COO of Septerna, Inc. (NASDAQ: SEPN), sold 3,990 shares of common stock on April 15, 2026 for about $97,343 and exercised options for 4,000 shares the same day. The transactions leave Bhatt with 174,209 shares directly owned. Septerna reported a narrower-than-expected fourth-quarter loss and revenue driven by a collab…
Corre Partners entities sold shares of NN Inc (NASDAQ: NNBR) across April 15-17, 2026, realizing $1.53 million in proceeds. The disposals occurred as NNBR climbed sharply week-over-week and year-to-date. Separately, NN Inc reported Q4 2025 results that missed analyst expectations, raised full-year new business guidance, and disclosed equipment purc…
Marie Mendoza, Kratos Defense & Security Solutions' senior vice president and general counsel, sold 1,500 shares on April 15, 2026 under a prearranged 10b5-1 plan. The company has since reported sizable government contract awards and an analyst upgrade amid an InvestingPro Fair Value assessment that rates the stock as overvalued.
Mark Vincent Parkinson, a director at The Ensign Group (ENSG), sold 100 shares on April 16, 2026 for $196.60 each, netting $19,660 and leaving him with 3,400 shares. Parkinson also received a 600-share grant on April 15, 2026 that vests in three equal annual installments beginning April 15, 2027. The stock trades around $200.11, up 57% over the pas…
Jarvis Scot B, a director at Kratos Defense & Security Solutions (NASDAQ: KTOS), sold 5,417 shares on April 16, 2026, for $75.90 per share, generating $411,150. The sale was carried out under a 10b5-1 trading plan established on September 15, 2025. The company has recently won substantial government contracts and received an analyst upgrade from Je…
Phillip D. Carrai, president of Kratos Defense & Security Solutions' STC Division, reported the sale of 6,490 shares of common stock on April 15, 2026, via a Form 4 filing. The trades, carried out under a pre-arranged 10b5-1 plan adopted August 26, 2025, comprised three transactions at weighted average prices between $74.0769 and $75.5619, prod…
Allan Tang, chief accounting officer at Yext, sold 10,000 common shares on April 15, 2026, for $36,161 as the stock traded near its 52-week low. The transaction followed a quarter in which Yext reported revenue slightly below expectations while narrowly missing adjusted EPS consensus but exceeding adjusted EBITDA forecasts, according to DA Davidson…
Anatol Kreitzer, MapLight Therapeutics' Chief Discovery Officer, sold 3,316 shares on April 15, 2026 at a weighted average price of $26.61 to satisfy statutory tax withholding tied to vesting restricted stock units. The transaction generated approximately $88,238 in proceeds. Since the sale, the stock has strengthened, trading at $30.05 and sitting…
Jonathan Gillis, Chief Accounting and Administrative Officer and Principal Accounting Officer at MapLight Therapeutics, sold 3,590 shares of the company’s voting common stock on April 15, 2026, to satisfy statutory tax withholding obligations tied to the vesting of restricted stock units. The transaction totaled about $95,529. Separately, several b…
Kristopher Hanson, General Counsel of MapLight Therapeutics (NASDAQ: MPLT), sold 1,827 shares of the company’s Voting Common Stock in three transactions on April 15 and 16, 2026, realizing $49,134. Following the disposals, Hanson retains direct ownership of 190,165 shares. Market commentary from InvestingPro flags potential overvaluation and overbo…
Copart Inc. Chief Executive Officer Jeffrey Liaw sold 26,213 shares on April 15, 2026, in transactions worth about $869,723, while simultaneously exercising options to acquire 50,075 shares. The stock has fallen roughly 44% over the past year and is trading close to its 52-week low. Separately, Copart arranged a $1.25 billion unsecured senior revol…
MapLight Therapeutics Chief Scientific Officer Lillie James Woodruff disposed of 4,413 shares of the company's Voting Common Stock on April 15-16, 2026, raising $122,573 in proceeds. The sales, disclosed on a Form 4, were made to satisfy statutory tax-withholding obligations tied to vested restricted stock units. Since the transactions, MPLT shares…
MapLight Therapeutics Chief Financial Officer Setia Vishwas sold 2,922 shares of the company’s voting common stock on April 15 and 16, 2026, in transactions that totaled $78,572. The sales, executed at prices between $26.87 and $27.49, were disclosed in a Form 4 filing with the SEC and were reported to satisfy statutory tax withholding tied to rest…
Portfolio manager Howard Hinds bought 5,500 shares of NYLI CBRE Global Infrastructure Megatrends Term Fund (NYSE: MEGI) on April 15, 2026, paying $15.146 per share for a total of $83,303. The transaction, disclosed in a Form 4/A filing with the Securities and Exchange Commission, leaves Hinds with 7,010 fund shares. MEGI is trading near its 52-week…
Meta Platforms director Robert M. Kimmitt sold 580 shares of Class A common stock on April 15, 2026, under a Rule 10b5-1 plan, generating $386,860. The company is simultaneously preparing a workforce reduction affecting roughly 10% of staff, while analysts maintain buy ratings and project continued advertising growth tied to AI investments.
Schrödinger President and CEO Farid Ramy exercised options to acquire 86,000 shares and sold those same shares on April 16 and 17, 2026, generating about $1,055,177 in proceeds. The transactions leave Ramy with 330,824 shares directly held. The company recently reported stronger-than-expected fourth-quarter and full-year 2025 revenue and is schedul…
